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Abstract. We present an improved adaptive approach for studying sys-
tems of ODEs aﬀected by parameter variability and state space uncer-
tainty. Our approach is based on a reformulation of the ODE problem as a
transport problem of a probability density describing the evolution of the
ensemble of systems in time. The resulting multidimensional problem is
solved by representing the probability density w.r.t. an adaptively chosen
Galerkin ansatz space of Gaussian densities. Due to our improvements in
adaptivity control, we substantially improved the overall performance of
the original algorithm and moreover inherited to the numerical scheme
the theoretical property that the number of Gaussian distributions re-
mains constant for linear ODEs. We illustrate the approach in applica-
tion to dynamical systems describing the pharmacokinetics of drugs and
xenobiotics, where variability in physiological parameters is important
to be considered.
1 Introduction
The medical beneﬁts of a drug depend not only on its biological eﬀect at the tar-
get protein, but also on its ”life cycle” within the organism - from its absorption
into the blood, distribution to tissue and its eventual breakdown or excretion by
the liver and kidneys. Pharmacokinetics is the study of the drug-organism inter-
action, in particular the investigation of absorption, distribution, metabolism,
and excretion (ADME) processes [9]. Studying ADME proﬁles is widely used in
drug discovery to understand the properties necessary to convert leads into good
medicaments [16,3]. Physiologically based pharmacokinetic (PBPK) models aim
at describing pharmacokinetic processes on a mechanistic basis. They model the
body as a network of organ or tissue compartments that are interconnected by
blood ﬂow (see Fig. 1). From a mathematical point of view, a PBPK model
comprises a system of coupled ordinary diﬀerential equations (ODEs). These
equations involve physiological and physicochemical parameters, each of which
is typically aﬀected with uncertainty and some degree of variability due to inter-
and intra-individual variations.
There exist theoretical and numerical tools for investigating ODEs with ini-
tial values and/or parameter uncertainty distributions. One class of approaches
is represented by Monte Carlo methods based on a sampling of the initial distri-
bution and subsequent solution of the underlying ODE for each of the sampling
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Fig. 1. A typical PBPK model. We distinguish between physiological and physicochem-
ical parameters. Physiological parameters comprise organ volumes and blood ﬂows;
physicochemical parameters such as partition coeﬃcients or solubility describe proper-
ties of the compound.
points (e.g. [15]). While this is the method of choice for problems with many
parameters and degrees of freedom in order to avoid the ”curse of dimensional-
ity”, the questions of numerical accuracy, reliability, and adaptivity still remain
partially unclear. A second class of methods are sparse grid techniques [17,4] or
particle methods [13,11]. In contrast to frequently used conventional grid meth-
ods, they both scale reasonably well for medium dimensional problems. Sparse
grids work best for smooth anisotropic densities with the grid being aligned to
the propagated objects. Adaptivity is used to generate an optimal sparse grid in
order to minimize the approximation error beneath some predeﬁned threshold.
However, for isotropic problems, e.g., for classical Liouville or Fokker–Planck
equations with Gaussian initial density, the adaptive sparse grid methods end
up by full grids, i.e., they are practically not applicable for high–dimensional
isotropic problems. A third class of approaches is known as the stochastic ﬁ-
nite elements (SFEMs) approach [7,8,12]. This method represents the overall
statistical response of the system by a linear combination of orthogonal basis
functions. However, in the available form, this approach cannot be applied to
higher dimensional problems with diﬀerent time and length scales as it is typical
for reaction kinetics and pharmacokinetic models.
In this article, we present a theoretical framework and an improved adap-
tive numerical approach for systems of ODEs aﬀected by parameter variabil-
ity and uncertainty distributions. The problem is reformulated in terms of the
well-established Frobenius-Perron theory, involving the semigroup of Frobenius-
Perron operators. In order to approximate the semi-group numerically, we adopt
and substantially extend the adaptive Gaussian-based particle method TRAIL
[6] that has originally been developed in the context of molecular dynamics [6]
and recently be transferred to reaction systems [5]. The approach is based on
two ingredients, (i) a time-dependent Galerkin ansatz space of Gaussian basis
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functions , and (ii) a propagation of the density w.r.t. the Galerkin ansatz space.
First applications to reaction kinetics demonstrated the potential of the method,
however the adaptivity control remained unsatisfactory from both the theoreti-
cal as well as the eﬃciency point of view. In this article we propose an improved
adaptivity control and demonstrate its power in application to typical systems
in pharmacokinetics, where variability and uncertainty play an important role.
2 Theoretical Background
Let us assume that the dynamics is deﬁned in terms of some ODE
x˙ = f(x|p) (1)
with some continuously diﬀerentiable right hand side f(·|p) : X → Rd para-
meterized by p ∈ Y ⊂ Rm, the vector of ﬁxed parameters. In the setting of
pharmacokinetics, X ⊂ Rd is the space of concentrations in d compartments,
and p represents physiological and physicochemical parameters. Given the ini-
tial state x(0) = x0, the solution of the initial value problem (1), x(t|p) : R → X
describes the concentration-time behavior in d diﬀerent tissues and can formally
be written in terms of the ﬂow Φt(·|p)
x(t|p) = Φt(x0|p) (2)
that is known to be invertible. Now assume that the parameters are speciﬁed
in terms of some statistical distribution in contrast to a ﬁxed numerical value.
Rather than solving (1) for some initial value x0 and a single set of parameters, we
are interested in capturing the eﬀects of distributed parameters on the evolution
of the dynamics, i.e, the initial value. Then, eq. (1) becomes an ODE with random
parameters and possibly random initial conditions that can be interpreted as
the evolution of an entire population. We can easily extend equation (1) to
account for inﬂuences of distributed parameters by extending the state space to
Z := X × Y and setting p˙ to zero
(
x˙
p˙
)
= F (x, p) =
(
f(x|p)
0
)
, (3)
since parameters are assumed to be constant in time.
Denote by L2(dxdp) the space of square integrable functions. The semigroup
of Frobenius-Perron operators Pt : L2(dxdp) → L2(dxdp) associated with (3)
describes the evolution of a given density u0 ∈ L2(dxdp) in time according to
Ptu0 = ut. Since the ﬂow Φt is invertible and diﬀerentiable, Pt is explicitly
deﬁned by
Ptu0(x, p) = u0
(
Φ−t(x, p)
) ·
∣∣∣∣dΦ
−t(x, p)
dxdp
∣∣∣∣ (4)
where the last term denotes the determinant of the Jacobian of Φ−t [10]. In broad
terms, deﬁnition (4) can be interpreted as follows: the value of density ut at (x, p)
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is given by the value of u0 at the pre-image of (x, p) corrected according to the
dynamics (expanding or contracting directions). The inﬁnitesimal generator A
of the semigroup of Frobenius-Perron operators is deﬁned by
Au = − div(F · u) = −
n∑
i=1
∂
∂zi
(F · u) , (5)
where z ∈ Z and n = d + m is the dimension of Z.
3 Adaptive Density Propagation
For the density propagation of Liouville type problems, Horenko and Weiser de-
veloped a multidimensional, adaptive particle method to describe the propaga-
tion of distributions in non-linear dynamical systems, called TRAIL (trapezoidal
rule for adaptive integration of Liouville dynamics) [6]. The adaptive discretiza-
tion scheme is based on a semi-discretization in time and subsequent approxi-
mation of the stationary spatial problem. The key idea is to approximate the
distribution u w.r.t. a time-adapted Galerkin basis of Gaussian ansatz functions.
Semi-discretization in time. Consider a probability distribution u0 characteriz-
ing variability and uncertainty of parameters and state variables. Then, at any
later time t > 0 the distribution ut is given by ut = Ptu0 involving the semi-group
of Frobenius-Perron operators. The basic idea of temporal semi-discretization
is to approximate {Pt}t≥0 by a simpler and numerically treatable semi-group
{Rt}t≥0. Loosely speaking, since Pt = exp(tA), we deﬁne Rt = r(tA) based
on some possible rational approximation r(·) of the exponential function exp(·).
Relevant in our context are Rt = (Id − tA/2)−1(Id + tA/2) denoting the trape-
zoidal rule and Rt = Id + tA denoting the explicit Euler scheme. Finally, the
numerical scheme exploits the semi-group property to approximate Pt for some
large t > 0 according to Pt = Pτn ◦ · · ·◦Pτn ≈ Rτn ◦ · · ·◦Rτn for some adaptively
chosen sequence of time steps t = τn + · · · + τ1.
Spatial discretization of stationary problem. At the very beginning, the initial
distribution u0 is approximated by a ﬁnite sum of Gaussian distributions, i.e.,
u0 =
Nt0∑
j=1
ωj(t0)Bj(· ; t0) + δt0 (6)
such that ‖δt0‖ < TOL, and for j = 1, . . . , Nt and t ≥ 0
Bj(z; t) := exp
{
1
2
(z − μj(t))T Gj(t)(z − μj(t)) + aj(t)
}
. (7)
The parameters μj(t), Gj(t), and aj(t) with j = 1, . . . , Nt denote the correspond-
ing means, inverses of the covariance matrices and normalization constants1,
1 The constants are chosen in such a way that Bj(·; t) is normalized to one, resulting
in aj(t) = ln(det(2πΣj(t))−
1
2 ).
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respectively. For details, see [6,5]. The initial approximation also deﬁnes the
Galerkin basis {Bj(·; t0) : j = 1, . . . , Nt0} at time t0.
In each step, the scheme comprises two steps: (i) adaptation of the Galerkin
basis w.r.t. the underlying dynamics; (ii) optimal representation of the time-
propagated density w.r.t. the adapted Galerkin basis. The propagation of the
Galerkin basis is performed w.r.t. to the locally (around each mean μj) linearized
dynamics guaranteeing that the Gaussian distributions remain Gaussian in time.
The parameters evolve according to the ODEs:
a˙j = −trace(DF (μj)) (8)
μ˙j = F (μj) (9)
G˙j = −DF (μj)TGj − Gj DF (μj), (10)
where DF (z) denotes the Jacobian of F at z ∈ Z. The representation of the time-
propagated density w.r.t. to the new Galerkin basis is realized via the trapezoidal
rule. The new coeﬃcients {ωj(t + τ) : j = 1, . . . , Nt} are optimized according to
‖δt+τ‖ =
∥∥∥(1 − τ
2
A
)
u(·, t + τ) −
(
1 +
τ
2
A
)
u(·, t)
∥∥∥ = min (11)
with
u(·, t + τ) =
Nt∑
j=1
ωj(t + τ)Bj(· ; t + τ) .
This can eﬃciently be performed by approximating the involved norm by a
Monte Carlo sampling, reformulating eq. (11) as a least squares problem to
be solved by means of a qr-algorithm [6], and noting that the action of the
inﬁnitesimal generator A on a Gaussian basis function can be computed exactly
at any given state z ∈ Z.
Adaptivity in time and space. The crucial ingredient of the TRAIL scheme is
the adaptive choice of the next time step and the adaptation of the Galerkin
basis (increasing or decreasing the number of basis functions) to keep the local
error below a user-deﬁned local tolerance TOL. In the original TRAIL scheme,
temporal adaptivity is realized by a step size control based on a comparison of
the trapezoidal rule and the Euler scheme, while spatial adaptivity is realized by
exploiting properties of the qr-algorithm in the optimization step combined with
some ”accuracy matching” (splitting of the local tolerance into some temporal
and spatial local tolerance), for details, see [6].
4 Improved Adaptivity
It is well-known that for linear ODEs an initial Gaussian distribution stays
Gaussian in time. In terms of the TRAIL scheme this means that the num-
ber of Gaussian basis functions should stay constant for linear ODEs. However,
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application to simple linear ODEs revealed that the number of Gaussians ba-
sis functions does in general not stay constant unless an a-priori unknown small
maximal time step is introduced. Since the numerical eﬀort of the TRAIL scheme
scales cubically with the number of Gaussian basis functions, this result is un-
satisfactory from both a numerical (adaptivity and eﬃciency) point of view as
well as from a theoretical point of view. Rather one would like to design an adap-
tivity control that allows for eﬃciency and inherits the theoretical properties for
linear ODEs to the numerical scheme. A thorough analysis of the performance
for linear problems revealed that new ansatz functions are added due to a too
coarse time discretization resulting in an overestimation of the spatial error. At
the same time, conservation of (probability) mass is poor. On the other hand,
bounding the time-step from above by some maximal time step (a-priori un-
known and in general depending on the ODE and the initial distribution) en-
forced a constant number of ansatz functions, but slowed down the integration
drastically.
The improved adaptivity control is based on the key idea to control the time-
step not only based on a comparison of two diﬀerent numerical schemes (in the
case of TRAIL the trapezoidal rule and the Euler scheme), but also based on
the spatial discretization error (estimator): For linear ODEs the time-step is re-
jected and subsequently decreased whenever the spatial error estimator exceeds
the spatial tolerance. In addition, we replace the Euler method by a second order
Runge-Kutta methods with Rt = Id + tA + t2A2/2 for a more eﬃcient perfor-
mance. For non-linear ODEs, the same is done based on a (local) linearization
of the ODE. Hence in broad terms, the time step is controlled in such a way
that a change in the number of basis functions is only due to non-linear eﬀects
of the underlying dynamics. In the next section we demonstrate the improved
adaptivity control in application to two typical pharamcokinetics models.
5 Numerical Examples
This section illustrates the numerical scheme in application to two model prob-
lems in pharmacokinetics. For a comparison of our method with the Monte Carlo
and the ﬁnite element approach in application to a small model from reaction
kinetics see [5].
The ﬁrst model is a very simple empirical two-compartment model that is fre-
quently used in population pharmacokinetics to analyze large data sets resulting
from clinical studies. It comprises two compartments, a central and a peripheral
one. Typically, the central compartment is thought of as blood compartment, while
the peripheral compartment is empirically chosen. In contrast to physiologically
based models this type of model is empirical. A compound is transferred from the
central to the peripheral compartment with some transfer rate kt, where it is elim-
inated with some elimination rate ke. The resulting ODEs are:
(
C˙c
C˙p
)
=
(−kt 0
kt −ke
) (
Cc
Cp
)
, (12)
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where Cc and Cp denote the concentrations of the compound in the central and
peripheral compartment. The evolution of the system for initially distributed
concentrations is depicted in Fig. 2. In the left column, ﬁxed parameter values
are chosen: kt = 0.5 and ke = 0.6, while in the right column parameter variability
according to kt ∼ N (0.5, 0.01) and ke ∼ N (0.6, 0.01) is taken into account.
Though variances of kt and ke are comparatively small, we observe consider-
able eﬀects on the joint distribution of central and peripheral concentrations. By
extending the state space, the ODE has become non-linear. Still, the number of
ansatz functions remains constant for the simulation time performed. This might
indicate that non-linear eﬀects have not been dominating. Applying the original
TRAIL scheme without the presented improvements results in a large number of
Gaussian ansatz functions (> 100 depending on the user prescribed tolerance)
for both the linear model (only concentrations) as well as the non-linear model
(concentration and parameters).
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Fig. 2. Simulations of system (12) with initial concentrations Cc(0) ∼ N (15, 1) and
Cp(0) ∼ N (2, 0.1). The left column shows the evolution of the initial density without
parameter variation, whereas in the right column the state space has been extended
by kt and ke. In both cases joint distributions of central and peripheral concentrations
are shown for time points t = 0, 0.4, 1.2 h (bottom to top).
Next, we consider the evolution of styrene concentrations after inhalation
in human body. We use a physiologically-based pharmacokinetic model that has
been developed in the context of toxicological risk assessment [14,1,2]. The PBPK
model comprises the organs/tissues liver, adipose, muscle, and vessel rich tissue
that are interconnected by the blood ﬂow. Based on the law of mass action a
system of coupled ODEs describing the time-evolution of styrene concentrations
in the above organs and tissues is established.
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Fig. 3. Simulations of the ten dimensional extended styrene system. Two dimensional
projections of the high dimensional joint distribution are shown for concentrations in
liver & vessel rich tissue (left), venous blood & liver (center), and Vmax with liver
concentration (right) are shown.
For org ∈ {liver, adipose, muscle, and vessel rich tissue} we get
Vorg
dCorg
dt
= Qorg · (Cart − Corg
Porg
), (13)
where Vorg, Qorg and Porg denote the volume, blood ﬂow and the so-called tissue
partition coeﬃcient, respectively. Saturable metabolization of styrene in liver is
assumed to be represented by an additional non-linear Michaelis-Menten term in
the liver compartment. The equations for venous and arterial blood are given by
Vven
dCven
dt
=
∑
i∈ tissues
Qi · Ci
Pi
− Cven · Qtot
Vart
dCart
dt
= Qtot · (Cven − Cart) + Qalv · (Cinh − Cart
Pair
) ,
where Cinh denotes styrene concentration in inhaled air, Qalv the alveolar ﬂow,
and Qtot the total blood ﬂow. In [2], it was found that the system is sensitive to
parameter uncertainty w.r.t. Vmax and Km in liver tissue, the blood:air partition
coeﬃcient Pair, and the partition coeﬃcient in adipose tissue Pfat. Hence, in
addition to ODEs for the concentrations we account for uncertainty by extending
the state space by these four parameters.
As a simulation output we obtain the evolution of a ten dimensional probabil-
ity distribution. Projections of this distribution onto one dimensional subspaces
representing a compartment (and not one of the four parameters) monitor the
concentration distribution in the respective compartment. Projections onto two
dimensions may reveal correlations of concentrations in diﬀerent compartments
or of concentrations with parameter values as shown in Fig. 3. The initially
uncorrelated distributions develop correlations in time, both between diﬀerent
tissues (Fig. 3, left and center) and between liver concentration and Vmax (Fig. 3,
right). As we would expect, liver concentration is negatively correlated to Vmax.
Also we would expect a positive correlation for liver and venous concentrations,
since both compartments are directly coupled by the liver blood ﬂow. The posi-
tive correlation of vessel rich and liver tissue on the other hand is not obvious on
ﬁrst sight. Knowledge about the eﬀect of variability and uncertainty is important
information for risk assessment studies, as in [1].
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6 Conclusions
We presented an improved approach for adaptive density propagation in the
context of ODEs aﬀected by parameter variability and state space uncertainty.
Our approach is based on a representation of the corresponding probability den-
sity w.r.t. an adaptively chosen Galerkin ansatz space of Gaussian distributions.
Due to our improvements in adaptivity control, the theoretical property that
the number of Gaussian distribution stays constant for linear ODEs is now in-
herited to the numerical scheme. Since the numerical eﬀorts scale with the third
power of the number of Gaussian basis functions, we managed to substantially
improve the overall performance. In addition the conservation of (probability)
mass improved.
Most often, Monte Carlo (MC) approaches are applied to study dynamical sys-
tems with distributed parameters and states. The MC methods generate an en-
semble of sampling points that approximate the statistical distribution. However,
in contrast to molecular dynamics, where the underlying Hamiltonian structure
implies conservation of phase volume and probability density along trajectories,
this properties does rarely hold in reaction kinetics and pharmacokinetics. As a
consequence, a single sampling point is of limited use and only in form of ex-
pectation values relevant information can be extracted. Moreover, the control of
the approximation error still remains partially unclear. The adaptive approach
to density propagation presented herein generates a continuous approximation
of the density in time. Since the density is approximated in terms of Gaussian
distributions, the approach is expected to be eﬃcient whenever the underlying
dynamics results in densities that are ”suﬃciently smooth”, as it seems to be the
case for pharmacokinetics problems. Due to the improved adaptivity control it
might also become possible to selectively study the inﬂuence of non-linear eﬀects
on the overall dynamics by monitoring the dimension of the Galerkin basis, i.e.,
the number of basis functions, since only the non-linear part of the dynamics
is able to increase or decrease the number of Gaussians. This would allow to
extract a completely diﬀerent and very interesting type of information and is
currently under investigation.
The results in application to pharmacokinetic models demonstrate the advan-
tages of the approach presented. As a result of the simulation studies, detailed
information on the distribution in state space and, e.g, the correlation between
diﬀerent parameters is available. These are important data for toxicological risk
assessments [1], or to study the variability of a drug exposure in an entire pop-
ulation (an information becoming more and more important).
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